nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Budget Impact Analysis of Nusinersen for Spinal Muscular Atrophy in China
|
Duan, Chengaxin |
|
|
34 |
C |
p. 9-13 |
artikel |
2 |
Copyright/Subscription
|
|
|
|
34 |
C |
p. vi |
artikel |
3 |
Cost Analysis of Hospitalization for COVID-19 in a Brazilian Public Teaching Hospital
|
Sousa, Fernanda Ferreira de |
|
|
34 |
C |
p. 48-54 |
artikel |
4 |
Cost-Effectiveness Analysis of Macitentan in Comparison With Bosentan in the Treatment of Pulmonary Arterial Hypertension in Iran
|
Ekhlasi, Mahna |
|
|
34 |
C |
p. 78-85 |
artikel |
5 |
Cost-Effectiveness of Empagliflozin on Top of Standard of Care for Heart Failure With Reduced Ejection Fraction in Singapore
|
Varghese, Lijoy |
|
|
34 |
C |
p. 108-117 |
artikel |
6 |
Cost of Home-Based Couples Human Immunodeficiency Virus Counseling and Testing and Human Immunodeficiency Virus Self-Testing During Pregnancy and Postpartum in Southwestern Kenya
|
Borgstede, Seth J. |
|
|
34 |
C |
p. 125-132 |
artikel |
7 |
Cost-Utility Analysis of Biologic Disease-Modifying Antirheumatic Drugs for Patients With Psoriatic Arthritis in Thailand
|
Dilokthornsakul, Piyameth |
|
|
34 |
C |
p. 40-47 |
artikel |
8 |
Current Medical Technology Reimbursement System in Japan
|
Matsumoto, Tomoko |
|
|
34 |
C |
p. 118-124 |
artikel |
9 |
Economic Evaluation of Immune Tolerance Induction in Children With Severe Hemophilia A and High-Responding Inhibitors: A Cost-Effectiveness Analysis of Prophylaxis With Emicizumab
|
Camelo, Ricardo Mesquita |
|
|
34 |
C |
p. 31-39 |
artikel |
10 |
Economic Evaluation of Selected Interleukin Inhibitors Versus Methotrexate for Moderate-to-Severe Plaque Psoriasis From the Philippine Payer Perspective
|
Kimwell, Miharu Jay M. |
|
|
34 |
C |
p. 100-107 |
artikel |
11 |
Economic Impact Analysis of Incorporation of Elecsys sFlt-1/PlGF Ratio Into Routine Practice for the Diagnosis and Follow-Up of Pregnant Women With Suspected Preeclampsia in Argentina
|
Garay, Osvaldo Ulises |
|
|
34 |
C |
p. 1-8 |
artikel |
12 |
Editorial Board
|
|
|
|
34 |
C |
p. i |
artikel |
13 |
Health State Utility Values of Type 2 Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis
|
Redenz, Gunther |
|
|
34 |
C |
p. 14-22 |
artikel |
14 |
Patient Access to Orphan Drugs Covered by Medical Insurance in China: Real-World Evidence From Patient Survey
|
Wang, Xiang |
|
|
34 |
C |
p. 71-77 |
artikel |
15 |
Patient-Reported Outcome Measures in Key Sub-Saharan African Languages to Promote Diversity: A Scoping Review
|
van Zyl, Chanel |
|
|
34 |
C |
p. 86-99 |
artikel |
16 |
Shall We Screen Lung Cancer With Low-Dose Computed Tomography? Cost-Effectiveness in Hungary
|
Nagy, Balázs |
|
|
34 |
C |
p. 55-64 |
artikel |
17 |
Supporting Decisions of the Brazilian Regulatory Agency for Supplementary Healthcare: A Case Study
|
Riera, Rachel |
|
|
34 |
C |
p. 65-70 |
artikel |
18 |
Table of Contents
|
|
|
|
34 |
C |
p. ii-v |
artikel |
19 |
The Value of Explicit, Deliberative, and Context-Specified Ethics Analysis for Health Technology Assessment: Evidence From a Novel Approach Piloted in South Africa
|
Krubiner, Carleigh B. |
|
|
34 |
C |
p. 23-30 |
artikel |